AbbVie, Inc. (ABBV)
288.52
+4.98
(+1.76%)
USD |
NYSE |
Nov 20, 15:00
AbbVie 30-Day Average Daily Volume : 5.258M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 5.258M |
| November 18, 2026 | 5.273M |
| November 17, 2026 | 5.314M |
| November 16, 2026 | 5.333M |
| November 13, 2026 | 5.401M |
| November 12, 2026 | 5.488M |
| November 11, 2026 | 5.456M |
| November 10, 2026 | 5.494M |
| November 09, 2026 | 5.510M |
| November 06, 2026 | 5.462M |
| November 05, 2026 | 5.379M |
| November 04, 2026 | 5.229M |
| November 03, 2026 | 5.063M |
| November 02, 2026 | 4.976M |
| October 30, 2026 | 4.796M |
| October 29, 2026 | 4.838M |
| October 28, 2026 | 4.811M |
| October 27, 2026 | 4.811M |
| October 26, 2026 | 4.873M |
| October 23, 2026 | 4.873M |
| October 22, 2026 | 4.862M |
| October 21, 2026 | 4.803M |
| October 20, 2026 | 4.785M |
| October 19, 2026 | 4.799M |
| October 16, 2026 | 4.817M |
| Date | Value |
|---|---|
| October 15, 2026 | 4.721M |
| October 14, 2026 | 4.607M |
| October 13, 2026 | 4.549M |
| October 12, 2026 | 4.479M |
| October 09, 2026 | 4.400M |
| October 08, 2026 | 4.415M |
| October 07, 2026 | 4.342M |
| October 06, 2026 | 4.262M |
| October 05, 2026 | 4.242M |
| October 02, 2026 | 4.162M |
| October 01, 2026 | 4.141M |
| September 30, 2026 | 4.196M |
| September 29, 2026 | 4.216M |
| September 28, 2026 | 4.238M |
| September 25, 2026 | 4.230M |
| September 24, 2026 | 4.291M |
| September 23, 2026 | 4.302M |
| September 22, 2026 | 4.336M |
| September 21, 2026 | 4.384M |
| September 18, 2026 | 4.434M |
| September 17, 2026 | 4.313M |
| September 16, 2026 | 4.369M |
| September 15, 2026 | 4.533M |
| September 14, 2026 | 4.610M |
| September 11, 2026 | 4.702M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 6.377M |
| Regeneron Pharmaceuticals, Inc. | 910037.9 |
| Biogen, Inc. | 1.237M |
| Amgen, Inc. | 2.663M |
| REGENXBIO, Inc. | 1.248M |